M. Miravitlles (Barcelona, Spain), D. Stolz (Basel, Switzerland)
Microbiology of COPD exacerbations at hospital admission: The ECOS study
B. G. Cosio, M. García-Núñez, E. Monsó, J. B. Soriano, R. Cordova, G. Peces-Barba, C. Esteban, J. Gea, F. Pozo, A. Agusti (Palma de Mallorca, Badalona, Baleares, Madrid, Galdakao, Barcelona, Bunyola, Spain)
|  |
Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD
J. Daniels, D. Snijders, R. Lutter, H. Jansen, W. Boersma (Amsterdam, Netherlands)
|  |
Impact of inhaled corticosteroid use on outcome in COPD patients hospitalised with pneumonia
A. Singanayagam, A. Akram, J. Chalmers, A. Hill (United Kingdom)
| |
Specific immune response against Haemophilus influenzae in stable COPD
L. Millares, A. Marín, J. García-Aymerich, J. Sauleda, S. Barea, M. García-Nuñez, J. M. Antó, E. Monsó (Badalona, Barcelona, Palma de Mallorca, Spain)
| |
Sputum neutrophil elastase in virus-induced COPD exacerbations correlate with clinical outcomes and virus load
P. Mallia, S. Message, M. Contoli, O. M. Kon, P. Alberto, K. Gray, T. Kebadze, S. Johnston (London, United Kingdom; Ferrara, Italy)
|  |
Vitamin D, innate immunity and outcomes in pneumonia and exacerbations of COPD
L. Leow, T. Simpson, R. Cursons, N. Karalus, R. Hancox (Hamilton, Dunedin, New Zealand)
| |
RT-PCR microarray detection of viral respiratory pathogens demonstrates the major role of human metapneumovirus and human rhinovirus in acute exacerbations of COPD in France
J. M. Perotin, L. Andreoletti, G. Deslee, F. Renois, S. Dury, V. Duval, C. de Champs, F. Lebargy (Reims, France)
| |
Rhinovirus infection induces increases in CD3+ and CD8+ T cells in BAL in COPD patients
P. Mallia, S. Message, M. Contoli, K. Gray, T. Kebadze, V. Laza-stanca, A. Papi, L. Stanciu, O. M. Kon, M. Johnson, S. Johnston (London, United Kingdom; Ferrara, Italy)
| |